Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 301 | 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY//LEVOSIMENDAN//PHARMACOLOGY & PHARMACY | 41522 |
| 980 | 2 | NICORANDIL//CALCIUM ANTAGONISTS//CALCIUM CHANNEL BLOCKERS | 10891 |
| 3349 | 1 | NISOLDIPINE//ELGODIPINE//GALLOPAMIL | 2038 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | NISOLDIPINE | authKW | 159405 | 2% | 25% | 41 |
| 2 | ELGODIPINE | authKW | 125247 | 0% | 90% | 9 |
| 3 | GALLOPAMIL | authKW | 110029 | 1% | 32% | 22 |
| 4 | NISOLDIPINE COAT CORE | authKW | 61851 | 0% | 100% | 4 |
| 5 | ANTIANGINA | authKW | 46388 | 0% | 100% | 3 |
| 6 | YM 16151 4 | authKW | 46388 | 0% | 100% | 3 |
| 7 | CARDIAC & CARDIOVASCULAR SYSTEM | WoSSC | 37474 | 53% | 0% | 1078 |
| 8 | CALCIUM ANTAGONISTS | authKW | 35796 | 3% | 4% | 62 |
| 9 | CAS 54527 84 3 | authKW | 30926 | 0% | 100% | 2 |
| 10 | CONTROLLED DELIVERY DILTIAZEM | authKW | 30926 | 0% | 100% | 2 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Cardiac & Cardiovascular System | 37474 | 53% | 0% | 1078 |
| 2 | Pharmacology & Pharmacy | 4793 | 29% | 0% | 601 |
| 3 | Medicine, General & Internal | 1925 | 15% | 0% | 314 |
| 4 | Peripheral Vascular Diseases | 1579 | 9% | 0% | 179 |
| 5 | Medicine, Research & Experimental | 134 | 4% | 0% | 87 |
| 6 | Chemistry, Medicinal | 56 | 2% | 0% | 48 |
| 7 | Anesthesiology | 26 | 1% | 0% | 21 |
| 8 | Toxicology | 24 | 2% | 0% | 38 |
| 9 | Critical Care Medicine | 21 | 1% | 0% | 20 |
| 10 | Respiratory System | 16 | 1% | 0% | 28 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | 39TH MARKET ST | 15463 | 0% | 100% | 1 |
| 2 | ADV MED TRAINING RETRAINING | 15463 | 0% | 100% | 1 |
| 3 | AZIENDA USL 5 PISA | 15463 | 0% | 100% | 1 |
| 4 | BP 53 X | 15463 | 0% | 100% | 1 |
| 5 | CANADIAN MULTI DILTIAZEM STUDY GRP | 15463 | 0% | 100% | 1 |
| 6 | CENT HOSP MED 1 INTENS CARE UNIT | 15463 | 0% | 100% | 1 |
| 7 | CIRCULATORY PATHOL | 15463 | 0% | 100% | 1 |
| 8 | CTMB | 15463 | 0% | 100% | 1 |
| 9 | HEART SECT | 15463 | 0% | 100% | 1 |
| 10 | IST MEDICINA INTERNA CARDIOL CARDIOCHIRURG | 15463 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | AMERICAN JOURNAL OF CARDIOLOGY | 26926 | 11% | 1% | 217 |
| 2 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 16831 | 5% | 1% | 110 |
| 3 | ZEITSCHRIFT FUR KARDIOLOGIE | 11940 | 3% | 1% | 56 |
| 4 | AMERICAN HEART JOURNAL | 10178 | 5% | 1% | 98 |
| 5 | CARDIOVASCULAR DRUGS AND THERAPY | 9576 | 2% | 2% | 35 |
| 6 | EUROPEAN HEART JOURNAL | 8817 | 4% | 1% | 77 |
| 7 | CARDIOLOGY | 8180 | 2% | 1% | 42 |
| 8 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 7064 | 2% | 1% | 47 |
| 9 | KARDIOLOGIYA | 6987 | 3% | 1% | 55 |
| 10 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 3903 | 2% | 1% | 46 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | NISOLDIPINE | 159405 | 2% | 25% | 41 | Search NISOLDIPINE | Search NISOLDIPINE |
| 2 | ELGODIPINE | 125247 | 0% | 90% | 9 | Search ELGODIPINE | Search ELGODIPINE |
| 3 | GALLOPAMIL | 110029 | 1% | 32% | 22 | Search GALLOPAMIL | Search GALLOPAMIL |
| 4 | NISOLDIPINE COAT CORE | 61851 | 0% | 100% | 4 | Search NISOLDIPINE+COAT+CORE | Search NISOLDIPINE+COAT+CORE |
| 5 | ANTIANGINA | 46388 | 0% | 100% | 3 | Search ANTIANGINA | Search ANTIANGINA |
| 6 | YM 16151 4 | 46388 | 0% | 100% | 3 | Search YM+16151+4 | Search YM+16151+4 |
| 7 | CALCIUM ANTAGONISTS | 35796 | 3% | 4% | 62 | Search CALCIUM+ANTAGONISTS | Search CALCIUM+ANTAGONISTS |
| 8 | CAS 54527 84 3 | 30926 | 0% | 100% | 2 | Search CAS+54527+84+3 | Search CAS+54527+84+3 |
| 9 | CONTROLLED DELIVERY DILTIAZEM | 30926 | 0% | 100% | 2 | Search CONTROLLED+DELIVERY+DILTIAZEM | Search CONTROLLED+DELIVERY+DILTIAZEM |
| 10 | DEFIANT STUDY | 30926 | 0% | 100% | 2 | Search DEFIANT+STUDY | Search DEFIANT+STUDY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |